Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
44.12
-1.59 (-3.48%)
At close: Jun 27, 2025, 4:00 PM
44.09
-0.03 (-0.07%)
After-hours: Jun 27, 2025, 7:24 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.87 billion as of June 27, 2025. Its market cap has increased by 36.67% in one year.
Market Cap
2.87B
Enterprise Value
2.18B
1-Year Change
36.67%
Ranking
Category
Stock Price
$44.12
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.87B, an increase of 244.29%. That is a compound annual growth rate of 29.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 2.98B | 14.24% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.79B |
| Johnson & Johnson | 367.12B |
| AbbVie | 326.98B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.17B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.12B |
| AstraZeneca | 215.99B |